Related links
Drug and Device Manufacturer Communications With
This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any
Learn more
PA-20-272: Administrative Supplements to Existing NIH
Oct 9, 2020 Given that the proposed supplement should not change the scope of the awarded parent project, it will typically not be needed. If new
Learn more
SCOPE of Pain: An Evaluation of an Opioid Risk
by DP Alford 2016 Cited by 109 The SCOPE of Pain program improved knowledge, attitudes, confidence, and self-reported clinical practice in safe opioid prescribing.
Learn more